The Synapse System redefines the treatment of substance use disorders by employing the latest neuroscientific technological advances. The technologies utilized in The Synapse System address the cognitive deficits that commonly contribute to negative outcomes.
My Brain Solution: Every Synapse patient undergoes computerized neurocognitive testing to identify the neurocognitive deficits that can interfere with learning the principles and skills needed for ongoing recovery. Based on the results of the neurocognitive assessment, every patient receives an individualized prescription of cognitive training to facilitate the building of brain structures underlying abilities such as working memory and executive functions. The Synapse cognitive assessment is unique in matching each patient’s brain profile to appropriate brain training games and insights to enhance brain fitness. Brain fitness refers to having the brain functionality - cognitive, emotional, and executive - to thrive in the environment we face each day, as well as, those we are likely to face in years to come. These brain training exercises are intended for daily use, but no less than 5 days per week for a minimum of 45 minutes per session. While brain training can be done at home, progress is monitored by a Synapse clinician from the Synapse office.
BrainPaint: Every Synapse patient undergoes a computerized evaluation for BrainPaint neurofeedback training. Neurofeedback training, a type of biofeedback that measures brain waves, provides trainees with information on their moment to moment brain function using real-time displays of brain activity. Given information on his brain function, the trainee learns to self-regulate his brain toward more efficient and optimal functioning. Research shows that neurofeedback places the individual in a more receptive state to new learning in both treatment and in 12-Step recovery. In addition, neurofeedback can be helpful for problems such as attention, anxiety, and depression.
N.E.B.A.: A thorough assessment and an exact diagnosis are essential to The Synapse System given that co-occurring disorders are not an exception; they are the norm. Furthermore, the clinical picture is complicated by the neurocognitive deficits associated with substance abuse - deficits that often continue months into the recovery process. Typically, diagnoses are made using no more than a behavioral checklist; however, technologies now exist to identify biomarkers indicative of specific pathology. The Synapse System utilizes N.E.B.A., the first FDA approved system that helps clarify a diagnosis of ADHD. In essence, NEBA helps the Synapse clinician answer the question, “Is it ADHD? Or, is it something else.”